SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: pgo-neil5/2/2011 8:15:07 AM
  Read Replies (1) of 3158
 
Teva tops Valeant's bid for CEPH...

finance.yahoo.com

NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd struck a deal to acquire U.S. specialty drugmaker Cephalon Inc (NasdaqGS:CEPH - News) for more than $6 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals International Inc and boosting its brand-name drug business.

Teva's (Tel Aviv:TEVA.TA - News; NasdaqGS:TEVA - News) $81.50-a-share deal is a nearly 12 percent premium over Valeant's (Toronto:VRX.TO - News) $73-a-share offer, which Valeant made public on March 29.

Israel-based Teva is best known as the world's largest maker of generic drugs, but it also has a significant business selling brand medicines that have patent protection. Adding Cephalon's pain, sleep and cancer drugs will help Teva reduce its dependence on its big-selling Copaxone multiple sclerosis medicine, which faces increasing competitive threats.

The deal is not conditioned on financing and is expected to be completed in the third quarter, the companies said.

Cephalon had urged shareholders to rebuff Valeant's overtures, and Cephalon shares had been trading above the Canadian company's offer.

Cephalon shares rose 5.5 percent to $81.25 in premarket trading. Teva shares rose 3.9 percent after the announcement.

Cephalon Chief Executive Officer Kevin Buchi said the deal with Teva followed a review of a wide range of strategic options.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext